Keratoconus is a serious eye disease that can change your life if ignored. Simple habits like rubbing your eyes can cause lasting harm.

Keratoconus is a disease that causes the cornea to slowly get thinner over time. It's the most common corneal dystrophy in the United States, affecting one in every 2,000 Americans. It is more common ...

Extension specialists share tips to help producers deal with pinkeye’s contagious nature and the damage it can cause to a cow ...

Keratoconus is a rare disease that arises in childhood and is characterized by compulsive eye rubbing and changing prescription. Rubbing your eyes harder and harder. Routine screen use, dry ...

This study aimed to evaluate the association between keratoconus and other psychological disorders, such as anxiety, intellectual disabilities, and obsessive compulsive disorder (OCD).

Intracorneal ring segments (ICRS) have been investigated recently as a surgical alternative to correct ectatic corneal diseases. Could ICRS implantation impact visual rehabilitation of keratoconus?

WebMD takes a look at Intacs, a medical device that is used in the treatment of the eye disorder known as keratoconus.

Glaukos Corporation GKOS recently announced that the second Phase 3 confirmatory pivotal trial for Epioxa, the company’s next-generation corneal cross-linking iLink therapy for the treatment of ...

Cornea and External Disease News AAO Choose DMEK Over DSEK After Glaucoma Surgery Descemet membrane endothelial keratoplasty provides better outcomes than Descemet-stripping in patients ...

Scleral contact lenses are hard and larger than your cornea. They rest on the sclera, ... Sjogren's syndrome, keratoconus (abnormally shaped cornea), and graft-versus-host disease.

Attention deficit-hyperactivity disorder (ADHD) was associated with a diagnosis of keratoconus in males, according to an Israeli population-based cross-sectional study. Looking at the medical ...

Glaukos (NYSE:GKOS) said the FDA has accepted its market application for its drug Epioxa for the treatment of the corneal disease keratoconus. The FDA has set a target action date for the ...